» Articles » PMID: 40034435

Elevated Glucose Increases Methicillin-resistant Staphylococcus Aureus Antibiotic Tolerance in a Cystic Fibrosis Airway Epithelial Cell Infection Model

Overview
Journal Res Sq
Date 2025 Mar 4
PMID 40034435
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In a healthy lung, the airway epithelium regulates glucose transport to maintain low glucose concentrations in the airway surface liquid (ASL). However, hyperglycemia and chronic lung diseases, such as cystic fibrosis (CF), can result in increased glucose in bronchial aspirates. People with CF are also at increased risk of lung infections caused by bacterial pathogens, including methicillin-resistant aureus. Yet, it is not known how increased airway glucose availability affects bacteria in chronic CF lung infections or impacts treatment outcomes.

Methods: To model the CF airways, we cultured immortalized CF (CFBE41o-) and non-CF (16HBE) human bronchial epithelial cells at air liquid interface (ALI). Glucose concentrations in the basolateral media were maintained at 5.5 mM or 12.5 mM, to mimic a normal and hyperglycemic milieu respectively. 2-deoxyglucose was added to high glucose culture media to restrict glucose availability. We collected ASL, basolateral media, and RNA from ALI cultures to assess the effects of elevated glucose. We also inoculated onto the apical surface of normal or high glucose ALI cultures and observed the results of antibiotic treatment post-inoculation. growth was measured by enumerating viable colony forming units (CFU) and with fluorescence microscopy. The effects of elevated glucose on growth and antibiotic treatment were also evaluated in standard bacterial culture medium and synthetic CF medium (SCFM).

Results: We found that glucose concentrations in the ASL of ALI cultures maintained in normal or high glucose mimicked levels measured in breath condensate assays from people with CF and hyperglycemia. Additionally, we found hyperglycemia increased aggregation and antibiotic resistance during infection of cells maintained in high glucose compared to normal glucose conditions. Heightened antibiotic tolerance or resistance as not observed during growth with elevated glucose. Limiting glucose with 2-deoxyglucose both decreased aggregation and reduced antibiotic resistance back to levels comparable to non-hyperglycemic conditions.

Conclusions: These data indicate hyperglycemia alters growth during infection and may reduce efficacy of antibiotic treatment. Glucose restriction is a potential option that could be explored to limit bacterial growth and improve treatment outcomes in chronic airway infections.

References
1.
Mallia P, Webber J, Gill S, Trujillo-Torralbo M, Calderazzo M, Finney L . Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018; 142(3):815-823.e6. PMC: 6127032. DOI: 10.1016/j.jaci.2017.10.017. View

2.
Vazquez Cegla A, Jones K, Cui G, Cottrill K, Koval M, McCarty N . Effects of hyperglycemia on airway epithelial barrier function in WT and CF 16HBE cells. Sci Rep. 2024; 14(1):25095. PMC: 11500396. DOI: 10.1038/s41598-024-76526-3. View

3.
Stentz F, Umpierrez G, Cuervo R, Kitabchi A . Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004; 53(8):2079-86. DOI: 10.2337/diabetes.53.8.2079. View

4.
Tsalamandris S, Antonopoulos A, Oikonomou E, Papamikroulis G, Vogiatzi G, Papaioannou S . The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur Cardiol. 2019; 14(1):50-59. PMC: 6523054. DOI: 10.15420/ecr.2018.33.1. View

5.
Shorr A, Myers D, Huang D, Nathanson B, Emons M, Kollef M . A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis. 2013; 13:268. PMC: 3681572. DOI: 10.1186/1471-2334-13-268. View